Evidence map›Paper›PMID 42277884›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026

MRI-based deep learning combined with radiomics for the preoperative prediction of lymphovascular invasion in patients with bladder cancer.

Chang Chen, Zhengye Tan, Lingkai Cai, Haonan Chen, Xiaotong Liu, Bo Liang, Meihua Jiang, Gongcheng Wang, Qiang Shao, Hongliang Que and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Chang Chen *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Zhengye Tan *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Lingkai Cai *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Haonan Chen *Department of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Xiaotong LiuDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bo LiangDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Meihua JiangDepartment of Radiology, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, 210029, China.
Gongcheng WangDepartment of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, 223001, China.
Qiang ShaoDepartment of Urology, Suzhou Hospital Affiliated of Nanjing Medical University, Suzhou, 215200, China.
Hongliang QueDepartment of Urology, Suzhou Hospital Affiliated of Nanjing Medical University, Suzhou, 215200, China.
Xuping JiangDepartment of Urology, Yixing People's Hospital, Wuxi, China.
Yuheng ZhangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Chenghao WangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Rongjie BaiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Hao YuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Xiao YangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China.
Qiang LuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China. doctorlvqiang@njmu.edu.cn.
Yuhao LinSEUIC Technologies Co., Ltd, Nanjing, China. linyuhao@seuic.com.
Qiang CaoDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Gulou District, Nanjing City, China. qiang_cao@126.com.

Funding

Jiangsu Provincial Health Department General Research Project M2024092Postdoctoral Research Foundation of Nanjing BSHNJ202210the National Natural Science Foundation of China 82273152, 82072832The Noncommunicated Chronic Diseases-National Science and Technology Major Project 2024ZD0525700
6 · The paper itself

Abstract

backgroundLymphovascular invasion (LVI) signifies poor prognosis in bladder cancer, yet reliable preoperative prediction remains challenging, limiting personalized treatment planning.

methodsIn this multi-center retrospective study, 543 bladder cancer patients were enrolled. Of these, 473 patients from two centers were randomly split into training and internal test sets at an 8:2 ratio, while 70 patients from six additional centers constituted an independent external test set. After tumor and peritumoral segmentation, a hybrid model that integrates deep learning and radiomics features was developed. The hybrid model was compared against ten baseline models, including image-only and radiomics-only deep learning models, as well as radiomics-based machine learning approaches. Model performance was assessed using the area under the receiver operating characteristic curve (AUC) with five-fold cross-validation. Prognostic value was evaluated by Kaplan-Meier survival analysis with the log-rank test.

resultsThe hybrid model achieved AUCs of 0.77 (internal test) and 0.75 (external test), surpassing all baseline models. The model-predicted LVI status significantly stratified overall survival in the training set (p < 0.001) and the internal test set (p = 0.003), with a non-significant trend observed in the external test set (p = 0.151).

conclusionThe proposed non-invasive hybrid model can accurately predict LVI status preoperatively and demonstrates prognostic potential, thereby aiding risk stratification in bladder cancer.

Indexed as

Deep LearningMagnetic Resonance ImagingUrinary Bladder NeoplasmsAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessPrognosisRadiomicsRetrospective StudiesBladder cancerDeep learningLymphovascular invasionRadiomics

Identifiers

PMID42277884
PMCPMC13483486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.